Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won two sizeable contracts, together worth over £2.1 million, to
Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced a trading update for the year ended 31 December 2022. Unaudited highlights for the
Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced the acquisition of Winterlight Labs Inc, a leader in monitoring cognitive impairment through free-speech
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced an expansion in the Chinese market through a strategic partnership with Luca Healthcare
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a £1.1m contract with a major pharmaceutical company to provide electronic
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has entered into an agreement to acquire the entire issued share
Cambridge Cognition’s Matthew Stork discusses interim results, growth drivers, their strengthened leadership team, new therapeutic areas and what investor can expect in the next six months in this exclusive interview with DirectorsTalk.
Cambridge Cognition (LON:COG) CEO Matthew Stork joins DirectorsTalk Interviews to discuss Interim results to 30 June. Matthew talks us through the highlights for the first half, explains what has been driving
The interim results for the six months ended 30 June 2022 were released earlier today on 20 September 2022. The Company will conduct a live presentation and Q&A session for
Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced its unaudited interim results for the six months ended 30 June 2022. The Company followed
© 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
